Presentation CIT 2018

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

REGISTER for free or LOG IN to view this content

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes
Coronary
DES/BRS/DCB
Imaging & Physiology
IVUS/NIRS
OCT
Presentation
CIT 2018
FUTURE trial

Up Next

More slides +

We Recommend